Fiche du document
- handle: 10670/1.evhvgb
- hal: hal-03435018
- doi: 10.1183/13993003.02419-2016
- SCIENCESPO: 2441/j1f5v7t58q9qk120nmahcadi
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1183/13993003.02419-2016
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/hdl/2441/j1f5v7t58q9qk120nmahcadi
Ce document est lié à :
info:eu-repo/grantAgreement/EC/FP7/295817/EU/From Silicosis to Chronic Respiratory diseases: an approach via epidemiological history (in France, Europe, Southern Africa, from the 1900s until today)/SILICOSIS
Sujets proches
Boeck's sarcoid Schaumann's disease Granuloma benignum Lymphogranulomatosis benigna Besnier-Boeck diseaseCiter ce document
Boris Duchemann et al., « Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris », HAL-SHS : histoire, philosophie et sociologie des sciences et des techniques, ID : 10.1183/13993003.02419-2016
Métriques
Partage / Export
Résumé
The objective of the study was to estimate the prevalence and incidence of interstitial lung diseases (ILDs) in Seine-Saint-Denis, a multi-ethnic county of Greater Paris, France. Patients with ILDs were identified between January and December 2012 by using several sources; all potentially involved medical specialists from public and private hospitals, community-based pulmonologists and general practitioners, and the Social Security system. Diagnoses were validated centrally by an expert multidisciplinary discussion. 1170 ILD cases were reported (crude overall prevalence: 97.9/10⁵ and incidence: 19.4/10⁵/year). In the 848 reviewed cases, the most prevalent diagnoses were sarcoidosis (42.6%), connective tissue diseases associated ILDs (CTDs-ILDs) (16%), idiopathic pulmonary fibrosis (IPF) (11.6%), and occupational ILDs (5.0%), which corresponded to a crude prevalence of 30.2/10⁵ for sarcoidosis, 12.1/10⁵ for CTDs-ILDs and 8.2/10⁵ for IPF. The prevalence of fibrotic idiopathic interstitial pneumonias, merging IPF, nonspecific interstitial pneumonia and cases registered with code J84.1 was 16.34/10⁵. An adjusted multinomial model demonstrated an increased risk of sarcoidosis in North Africans and Afro-Caribbeans and of CTDs-ILDs in Afro-Caribbeans, compared to that in Europeans. This study, with a comprehensive recruitment and stringent diagnostic criteria, emphasises the importance of secondary ILDs, particularly CTDs-ILDs and the relatively low prevalence of IPF, and confirms that sarcoidosis is a rare disease in France. [résumé éditeur]